141. Mesial temporal lobe epilepsy with hippocampal sclerosis Clinical trials / Disease details


Clinical trial : 1 Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05135091
(ClinicalTrials.gov)
June 16, 202216/11/2021FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe EpilepsyA First-In-Human (FIH) Study of Inhibitory Interneurons (NRTX- 1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)Mesial Temporal Lobe Epilepsy With Hippocampal SclerosisBiological: NRTX-1001;Procedure: Sham ComparatorNeurona TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)Recruiting18 Years55 YearsAll40Phase 1/Phase 2United States